• Otolaryngology
• Surgical Oncology

Allen S. Ho, MD, is a board-certified, fellowship-trained head and neck surgeon. His practice focuses on the treatment of head and neck tumors, including HPV(+) throat cancers and thyroid malignancies. He serves as Director of the Head and Neck Cancer Program and Co-Director of the Thyroid Cancer Program, and runs the multidisciplinary Cedars-Sinai Head and Neck Tumor Board. Dr. Ho’s research interests are highly integrated into his clinical practice. His current efforts lie in thyroid cancer risk stratification, cancer proteomics, and HPV(+) oropharyngeal cancer pathogenesis. Dr. Ho has published as lead author in journals that include Nature Genetics, JCO, JCI, JAMA Oncology, and Thyroid, and is Co-Editor of the textbook Multidisciplinary Care of the Head and Neck Cancer Patient (Springer 2018). Dr. Ho serves on national committees within the AHNS and ATA, and is PI for a protocol investigating thyroid cancer active surveillance (ClinicalTrials.gov ID: NCT02609685). He maintains expertise in transoral robotic surgery (TORS), minimally invasive thyroidectomy approaches, and nerve preservation techniques. Dr. Ho’s overarching aim is to partner with patients to optimize treatment and provide compassionate, exceptional care.

View NIH Biographical Sketch as a PDF

• Undergraduate: Harvard University, 2000
• Fellowship: National Institutes of Health, 2004
• Medical School: UCLA School of Medicine, 2006
• Residency: Stanford University School of Medicine, 2011
• Fellowship: Memorial Sloan Kettering Cancer Center, 2013

View CV as a PDF

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Head and Neck Cancer Program
• Department of Surgery
• Thyroid Cancer Program
• Cancer
• Surgery
• Thyroid and Parathyroid Disorders
• Endocrine Surgery Otolaryngology

• HHMI-NIH Continuing Support Scholarship
• Adenoid Cystic Carcinoma Foundation Grant
• Health Network Foundation Grant
• Donna and Jesse Garber Award for Cancer Research
• Precision Health Initiative Grant

Click here for a list of peer-reviewed publications.

• Ho AS, Lee W, Chan TA et al. The mutational landscape of adenoid cystic carcinoma. Nature Genetics 2013;45(7):791-798.
• Ho AS, Ochoa A, Tepe J, et al. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma. Journal of Clinical Investigation. 2019 Aug [Epub ahead of print].
• Ho AS, Daskivich, TJ, Sacks WL, Zumsteg ZS. Parallels between low-risk prostate and thyroid cancer. JAMA Oncology. 2019 Jul 1;5(7):975-983.